Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 17/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | FAP | Q12884 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4405976 | 0.88 | DPP4 (0.52) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4412456 | 0.88 | DPP4 (0.51) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4407462 | 0.88 | DPP4 (0.50) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4405184 | 0.86 | DPP4 (0.49) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4412404 | 0.85 | DPP4 (0.54) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4398905 | 0.84 | DPP4 (0.53) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4399247 | 0.84 | DPP4 (0.53) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4399302 | 0.83 | DPP4 (0.47) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4415403 | 0.82 | DPP4 (0.47) | DPP4DPP7DPP8CYP3A4DPP9 | |
| SCHEMBL4406307 | 0.82 | DPP4 (0.55) | DPP4DPP7DPP8CYP3A4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156465-A1 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2009-06-18 | — | — | US | claimed |
| US-20090156465-A1 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156465-A1 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | DPP4, DPP3, DPP7 | DPP4 1/4885DPP7 3/4885DPP8 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.